Motus GI Medical Technologies Ltd is developing a single-use device that attaches to a standard colonoscope, thereby integrating colon cleansing, screening and treatment into one procedure. The device creates turbulence within the colon using water jets. The colon's fecal fluids are evacuated by the system.
Conducting clinical trials in the EU.
On September, 2011, Motus announced the closing of its Series A investment round. The $13.5 million investment was led by two US based VC.
Mark Pomeranz, CEO
Cell: +1 908 745 8599
Israel Office: +972 46 214447
Israel Fax: +972 46 214442